ABUS - Arbutus Biopharma Corporation Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS). Get the latest Arbutus Biopharma Corp (ABUS) real-time quote, historical 3 hours ago. Stock market today: Nasdaq, S&P lead stocks lower ahead of. Arbutus Biopharma (ABUS) Stock Price Performance. License Error: Access from crawling bot. Arbutus Biopharma (ABUS) Stock Key Data. SummaryAdditional Data. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange. Get Arbutus Biopharma Corp (ABUS.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
Arbutus Biopharma Corporation's stock symbol is ABUS and currently trades under NASDAQ. It's current price per share is approximately $ When is Arbutus. Check if ABUS Stock has a Buy or Sell Evaluation. ABUS Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Arbutus Biopharma Corporation News. ABUS Arbutus Biopharma Corp. 17, $ $ (%). Today. Watchers, 17, Wk Low, $ Wk High, $ Market Cap, $M. ABUS stock quote, as well as option quotes for Arbutus Biopharma Corporation. Earn recurring monthly income from ABUS via covered calls. Stock Information · Financial Information · Corporate Governance · Press Releases · Events Arbutus Biopharma Corporation (NASDAQ:ABUS) is a clinical-stage. Arbutus Biopharma Corporation (ABUS) has a Smart Score of 4 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Discover real-time Arbutus Biopharma Corporation Common Stock (ABUS) stock prices, quotes, historical data, news, and Insights for informed trading and. View a financial market summary for ABUS including stock price quote, trading volume, volatility, options volume, statistics, and other important company. Arbutus Biopharma Corp (ABUS) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. Why Arbutus Biopharma Stock Is Sinking Today. After a strong start to , the virology-focused biopharma company has hit a regulatory speed bump. Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional.
On average, Wall Street analysts predict that Arbutus Biopharma's share price could reach $ by Aug 2, The average Arbutus Biopharma stock price. ABUS | Complete Arbutus Biopharma Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Stock analysis for Arbutus Biopharma Corp (ABUS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. View the real-time ABUS price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. Why Arbutus Biopharma Stock Is Sinking Today. After a strong start to , the virology-focused biopharma company has hit a regulatory speed bump. ABUS - Arbutus Biopharma Corp - Stock screener for investors and traders, financial visualizations. The current price of ABUS is USD — it has increased by % in the past 24 hours. Watch Arbutus Biopharma Corporation stock price performance more closely. In the current month, ABUS has received 8 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ABUS average Analyst price target in the past 3 months is $ Get the latest updates on Arbutus Biopharma Corporation Common Stock (ABUS) pre market trades, share volumes, and more. Make informed investments with.
Stock Information · Financial Information · Corporate Governance · Press Releases · Events Arbutus Biopharma Corporation (NASDAQ:ABUS) is a clinical-stage. Arbutus Biopharma Corp ABUS:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date07/26/24 · 52 Week Low Complete Arbutus Biopharma Corp. stock information by Barron's. View real-time ABUS stock price and news, along with industry-best analysis. The latest Arbutus Biopharma stock prices, stock quotes, news, and ABUS history to help you invest and trade smarter. Stock Price Forecast. The 3 analysts with month price forecasts for Arbutus Biopharma stock have an average target of , with a low estimate of and a.
Cramer: This biotech stock could be worth over $100 billion on an FDA approval
Research Arbutus Biopharma's (Nasdaq:ABUS) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. Earnings Date. 01/01/ EPS EST. EPS PRIOR. EPS. Rev guidance. $10,,, ABUS Stock Price. Upcoming ABUS Catalysts. Drug. Stage. Is Arbutus Biopharma (NASDAQ:ABUS) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends. View ABUS Stock Real Time Quote, Arbutus Biopharma Corporation stock price with interactive chart, get the latest alerts for Arbutus Biopharma Corporation.
Making 1 Million A Year | Good Company To Refinance Home Loan